Alnylam Pharmaceuticals, Inc. Share Price
NASDAQ: ALNY | Large CapAlnylam Pharmaceuticals, Inc. Stock Performance
Alnylam Pharmaceuticals, Inc. Share Price Today
As of 29 October 2026, Alnylam Pharmaceuticals, Inc.'s share price is $232.31. The stock opened at $223.81, compared to its previous close of $227.01. During today's trading session, Alnylam Pharmaceuticals, Inc.'s share price traded between $222.13 and $232.88, with an average price of $227.50. Over the past 52 weeks, the stock has recorded a high of $483.80 and a low of $197.95. In terms of performance, Alnylam Pharmaceuticals, Inc.'s share price has declined by 24.91% over the last six months and is down 49.06% on a year-on-year basis.
Alnylam Pharmaceuticals, Inc. Share Price Chart
Alnylam Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Alnylam Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
Alnylam Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $247.47 | $232.54 | -5.86% |
Sep 2026 | $241.47 | $247.01 | +4.46% |
Aug 2026 | $208.03 | $236.46 | +15.05% |
Jul 2026 | $304.71 | $205.52 | -31.68% |
Jun 2026 | $300.50 | $300.83 | -0.36% |
May 2026 | $309.32 | $301.91 | -2.41% |
Apr 2026 | $332.38 | $309.37 | -6.50% |
Mar 2026 | $333.76 | $330.89 | -0.54% |
Feb 2026 | $339.06 | $332.69 | -1.56% |
Jan 2026 | $401.06 | $337.96 | -15.02% |
Dec 2025 | $452.11 | $397.71 | -11.86% |
Nov 2025 | $455.02 | $451.21 | -1.07% |